Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-06

Clinical Trial Update: High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients [Phase 4]

View source ↗

Summary

This Phase 4 trial comparing high-dose quinapril to low-dose quinapril plus amlodipine in high-risk hypertension was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • Quinapril (quinapril)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Hypertension | Phase 4 | Status: TERMINATED